1 Shimizu K, "Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer" 5 : 585-590, 2010
2 Curiel TJ, "Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival" 10 : 942-949, 2004
3 Correale P, "Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy" 33 : 435-441, 2010
4 Correale P, "Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy" 33 : 435-441, 2010
5 Beyer M, "Reduced frequencies and suppressive function of CD4+ CD25high regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine" 106 : 2018-2025, 2005
6 이신화, "Proliferation of CD4+CD25high+Foxp3+ regulatory T lymphocytes in ex vivo expanded ascitic fluid from primary and recurrent ovarian carcinoma" 대한부인종양콜포스코피학회 21 (21): 38-44, 2010
7 Barnett JC, "Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotype" 116 : 556-562, 2010
8 Zitvogel L, "Cancer despite immunosurveillance: immunoselection and immunosubversion" 6 : 715-727, 2006
9 Aruga T, "A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer" 22 : 273-278, 2009
10 Aruga T, "A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti- tumor response in patients with breast cancer" 22 : 273-278, 2009